Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Likewise, STV insiders make investments

Wed 21 May 2025 14:46

(Sharecast News) - Among the companies disclosing director dealings to the London market on Wednesday were Likewise Group and STV Group, with insiders at both firms purchasing shares. Paul Bassi, the non-executive chairman of floor coverings distributor Likewise Group, acquired 500,000 ordinary shares at a price of 19.04p each.

The purchase increased his total beneficial holding to 3.5 million shares, representing approximately 1.42% of the company's voting rights.

Rufus Radcliffe, chief executive officer of broadcaster STV Group, meanwhile purchased 48,331 shares at a price of 163p apiece.

That transaction took place on 19 May on the London Stock Exchange.

At 1442 BST, shares in Likewise Group were up 2.98% at 20.19p, while those in STV Group were down 0.31% at 161.5p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Likewise Group (LIKE) Director name: Bassi,Paul Amount purchased: 500,000 @ 19.04p Value: £95,190.00

Stv Group (STVG) Director name: Radcliffe,Rufus Amount purchased: 48,331 @ 163.00p Value: £78,779.53

Scancell Holdings (SCLP) Director name: Diggle ,Martin Amount purchased: 402,952 @ 9.00p Value: £36,265.68

Caledonia Mining Corporation (di) (CMCL) Director name: Gapare,Victor Amount purchased: 2,280 @ $16.96 Value: $31,886.53

Arecor Therapeutics (AREC) Director name: Richards,Andrew Amount purchased: 31,750 @ 46.97p Value: £14,912.98

Arecor Therapeutics (AREC) Director name: Howell,Sarah Jennifer Amount purchased: 21,077 @ 46.97p Value: £9,899.87

Transense Technologies (TRT) Director name: Maughan,Ryan Amount purchased: 3,352 @ 134.00p Value: £4,491.68

Scancell Holdings (SCLP) Director name: Diggle ,Martin Amount purchased: 49,868 @ 9.00p Value: £4,488.12

Scancell Holdings (SCLP) Director name: Diggle ,Martin Amount purchased: 44,944 @ 9.00p Value: £4,044.96

Krm22 (KRM) Director name: Jones,Garry Amount purchased: 3,125 @ 32.00p Value: £1,000.00

Krm22 (KRM) Director name: Jones,Garry Amount purchased: 3,154 @ 31.70p Value: £999.82

Transense Technologies (TRT) Director name: Maughan,Ryan Amount purchased: 368 @ 133.50p Value: £491.28

Share this article

Related Sharecast Articles

Thu 15 Oct 2026 14:36
Director dealings: British American Tobacco's Karen Guerra purchases shares
(Sharecast News) - British American Tobacco revealed on Thursday that non-executive director Karen Guerra had acquired 6,000 ordinary shares in the FTSE 100-listed tobacco giant.
Wed 14 Oct 2026 14:28
Director dealings: Convatec non-executive director makes share purchase
(Sharecast News) - Convatec revealed on Wednesday that non-executive director Jens Viebke had acquired 24,400 ordinary shares in the FTSE 100-listed medical products and technology firm.
Tue 13 Oct 2026 14:15
Director dealings: Mortgage Advice Bureau chairman snaps up shares
(Sharecast News) - Mortgage Advice Bureau revealed on Tuesday that non-executive chairman Michael Jones had acquired 5,833 ordinary shares in the AIM-listed property finance platform operator.
Mon 12 Oct 2026 13:08
Director dealings: Insig Ai CEO raises stake
(Sharecast News) - Insig Ai revealed on Monday at chief executive Richard Bernstein had acquired 400,000 ordinary shares in the AIM-listed data infrastructure and machine learning firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026